Jake joined British Patient Capital in December 2020 from BioCity, a UK life sciences incubator and accelerator, where he focused on early stage life sciences investments. Previously, he worked as a lab scientist at Pfizer, AstraZeneca, and Source Bioscience. Jake holds a Masters in Applied Biopharmaceutical Biotechnology and Entrepreneurship from the University of Nottingham, as well as a BSc in Biochemistry from the University of Bath.